TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) just unveiled an announcement.
Kilitch Drugs (India) Limited announced the approval and allotment of 13,98,463 equity shares on a rights basis to eligible shareholders at an issue price of Rs. 357 per share. This move, approved by the Board of Directors, is expected to enhance the company’s capital structure and provide additional resources for its operational and strategic initiatives.
More about Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of a variety of pharmaceutical products. The company is known for its commitment to quality and innovation in the healthcare sector.
Average Trading Volume: 3,224
Technical Sentiment Signal: Buy
Current Market Cap: 7.08B INR
See more data about KILITCH stock on TipRanks’ Stock Analysis page.